Literature DB >> 4131798

The leukokinin system; its role in fluid accumulation in malignancy and inflammation.

L M Greenbaum, A Prakash, G Semente, M Johnston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4131798     DOI: 10.1007/bf01986490

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


× No keyword cloud information.
  5 in total

1.  Leukokinin-forming system in the ascitic fluid of a murine mastocytoma.

Authors:  M M Johnston; L M Greenbaum
Journal:  Biochem Pharmacol       Date:  1973-06-01       Impact factor: 5.858

2.  Pepstatin, a new pepsin inhibitor produced by Actinomycetes.

Authors:  H Umezawa; T Aoyagi; H Morishima; M Matsuzaki; M Hamada
Journal:  J Antibiot (Tokyo)       Date:  1970-05       Impact factor: 2.649

3.  Studies on leukokinins. 3. Pharmacological activities of leukokinins M and PMN.

Authors:  R Freer; J Chang; L M Greenbaum
Journal:  Biochem Pharmacol       Date:  1972-12-01       Impact factor: 5.858

4.  Studies on leukokinins. II. Studies on the formation, partial amino acid sequence and chemical properties of leukokinins M and PMN.

Authors:  J Chang; R Freer; R Stella; L M Greenbaum
Journal:  Biochem Pharmacol       Date:  1972-12-01       Impact factor: 5.858

Review 5.  Leukocyte kininogenases and leukokinins from normal and malignant cells.

Authors:  L M Greenbaum
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

  5 in total
  3 in total

1.  Leukokinin-H generated from human ascites fluid; its isolation and pharmacology.

Authors:  P Grebow; A Prakash; L M Greenbaum
Journal:  Agents Actions       Date:  1979-08

Review 2.  Biologically active products from African Trypanosomes.

Authors:  I Tizard; K H Nielsen; J R Seed; J E Hall
Journal:  Microbiol Rev       Date:  1978-12

3.  Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization.

Authors:  H H Newball; R W Berninger; R C Talamo; L M Lichtenstein
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.